Peptide boom poses ‘growing risk’ to businesses: lawyers

Pharmacists may start to see more patients who have sourced peptides online, which could have implications for medication management and risk, specialists warn Pharmacists and compounders “should consider whether their clinical governance and documentation adequately address unapproved peptide use”, amid the surging popularity of the mini-proteins, lawyers say. Earlier this month, the Therapeutic Goods Administration